Sandra Di Gregorio

441 total citations
17 papers, 323 citations indexed

About

Sandra Di Gregorio is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Sandra Di Gregorio has authored 17 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Sandra Di Gregorio's work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Eosinophilic Disorders and Syndromes (7 papers). Sandra Di Gregorio is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Eosinophilic Disorders and Syndromes (7 papers). Sandra Di Gregorio collaborates with scholars based in Italy and Argentina. Sandra Di Gregorio's co-authors include Maria Stella Pennisi, Stefania Stella, Livia Manzella, Michele Massimino, Silvia Rita Vitale, Adriana Puma, Chiara Romano, Elena Tirrò, Paolo Vigneri and Federica Martorana and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Sandra Di Gregorio

17 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Di Gregorio Italy 10 109 108 101 88 66 17 323
Adriana Puma Italy 12 163 1.5× 141 1.3× 140 1.4× 145 1.6× 93 1.4× 22 452
Martin Kirschner Germany 13 134 1.2× 196 1.8× 105 1.0× 12 0.1× 87 1.3× 33 389
Lisa Bruns Germany 6 34 0.3× 64 0.6× 90 0.9× 28 0.3× 63 1.0× 8 300
Grazia Sortino Italy 7 204 1.9× 158 1.5× 130 1.3× 23 0.3× 70 1.1× 14 356
Alice Huntsman Labed United States 4 55 0.5× 112 1.0× 70 0.7× 25 0.3× 27 0.4× 6 433
Yasuyuki Kaneta Japan 8 47 0.4× 174 1.6× 44 0.4× 11 0.1× 75 1.1× 10 290
M Siena Italy 9 74 0.7× 162 1.5× 35 0.3× 11 0.1× 101 1.5× 11 400
Juan Luiz Coelho‐Silva Brazil 10 78 0.7× 155 1.4× 54 0.5× 13 0.1× 43 0.7× 35 264
Carine Lefèvre France 8 58 0.5× 174 1.6× 46 0.5× 123 1.4× 23 0.3× 11 339
Charles Sawyers United States 5 93 0.9× 148 1.4× 53 0.5× 7 0.1× 68 1.0× 7 253

Countries citing papers authored by Sandra Di Gregorio

Since Specialization
Citations

This map shows the geographic impact of Sandra Di Gregorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Di Gregorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Di Gregorio more than expected).

Fields of papers citing papers by Sandra Di Gregorio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Di Gregorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Di Gregorio. The network helps show where Sandra Di Gregorio may publish in the future.

Co-authorship network of co-authors of Sandra Di Gregorio

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Di Gregorio. A scholar is included among the top collaborators of Sandra Di Gregorio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Di Gregorio. Sandra Di Gregorio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pennisi, Maria Stella, Sandra Di Gregorio, Elena Tirrò, et al.. (2023). Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports. SHILAP Revista de lepidopterología. 15(2). 317–324. 1 indexed citations
2.
Romano, Chiara, Sandra Di Gregorio, Maria Stella Pennisi, et al.. (2022). Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis. Molecular Biology Reports. 49(9). 9059–9064. 3 indexed citations
3.
Tirrò, Elena, Michele Massimino, Chiara Romano, et al.. (2021). Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma. Frontiers in Oncology. 10. 612385–612385. 31 indexed citations
4.
Massimino, Michele, Elena Tirrò, Stefania Stella, et al.. (2021). Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts. Frontiers in Pharmacology. 12. 669469–669469. 13 indexed citations
5.
Stella, Stefania, Michele Massimino, Livia Manzella, et al.. (2021). Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes. International Journal of Molecular Sciences. 22(2). 486–486. 9 indexed citations
6.
Romano, Chiara, Federica Martorana, Maria Stella Pennisi, et al.. (2021). Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer. International Journal of Molecular Sciences. 22(14). 7707–7707. 22 indexed citations
7.
Manzella, Livia, Elena Tirrò, Silvia Rita Vitale, et al.. (2020). Optimal Response in a Patient With CML Expressing BCR–ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report. In Vivo. 34(3). 1481–1486. 3 indexed citations
8.
Massimino, Michele, Stefania Stella, Elena Tirrò, et al.. (2020). ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives. Anticancer Research. 40(5). 2457–2465. 30 indexed citations
9.
Massimino, Michele, Elena Tirrò, Stefania Stella, et al.. (2020). Targeting BCL-2 as a Therapeutic Strategy for Primary p210BCR-ABL1-positive B-ALL Cells. In Vivo. 34(2). 511–516. 8 indexed citations
10.
Stella, Stefania, Elena Tirrò, Michele Massimino, et al.. (2019). Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib. In Vivo. 33(5). 1593–1598. 6 indexed citations
11.
Tirrò, Elena, Michele Massimino, Stefania Stella, et al.. (2019). Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22). Anticancer Research. 39(7). 3893–3899. 12 indexed citations
12.
Tirrò, Elena, Stefania Stella, Michele Massimino, et al.. (2019). Colony-Forming Cell Assay Detecting the Co-Expression of <b><i>JAK2</i></b><sup>V617F</sup> and <b><i>BCR-ABL1</i></b> in the Same Clone: A Case Report. Acta Haematologica. 141(4). 261–267. 9 indexed citations
13.
Pennisi, Maria Stella, Stefania Stella, Silvia Rita Vitale, et al.. (2019). BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors. Frontiers in Oncology. 9. 764–764. 12 indexed citations
14.
Stella, Stefania, Michele Massimino, Elena Tirrò, et al.. (2019). Detection and Clinical Implications of a Novel BCR-ABL1 E12A2 Insertion/Deletion in a CML Patient Expressing the E13A2 Isoform. Anticancer Research. 39(12). 6965–6971. 9 indexed citations
15.
Manzella, Livia, Michele Massimino, Stefania Stella, et al.. (2019). Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment. International Journal of Molecular Sciences. 20(13). 3258–3258. 41 indexed citations
16.
Tirrò, Elena, Federica Martorana, Chiara Romano, et al.. (2019). Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice. Genes. 10(9). 709–709. 68 indexed citations
17.
Aloisi, Alessandra, Sandra Di Gregorio, Fabio Stagno, et al.. (2005). BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B. Blood. 107(4). 1591–1598. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana Puma Breakdown of academic impact, for papers by Martin Kirschner Breakdown of academic impact, for papers by Lisa Bruns Breakdown of academic impact, for papers by Grazia Sortino Breakdown of academic impact, for papers by Alice Huntsman Labed Breakdown of academic impact, for papers by Yasuyuki Kaneta Breakdown of academic impact, for papers by M Siena Breakdown of academic impact, for papers by Juan Luiz Coelho‐Silva Breakdown of academic impact, for papers by Carine Lefèvre Breakdown of academic impact, for papers by Charles Sawyers
Rankless by CCL
2026